Pfizer’s Centers for Therapeutic Innovation (CTI) Harvard Case Solution & Analysis

Pfizar started its four research units, in 2010, near to leading academic medical centers, or hospitals that are integrated with medical schools. These units were established in multiple cities, including San Francisco, New York, San Diego, and Boston. The basic objective of these research units was to promote and strengthen the collaboration between Pfizar and academic medical researchers with an aim to increase the innovation in drug development. In order to minimize the time, the project team comprised of academics working together with Pfizar scientists to quickly introduce a therapeutic drug to the market. This case determines a framework developed by Pfizar for the academic collaboration. What were the potential risks and opportunities associated with this framework? What could be the path to bring the framework to a leading position in the future? In what manners, the other prominent pharmaceutical companies’ framework can cause a threat for the Pfizar framework of academic collaboration?

Pfizer’s Centers for Therapeutic Innovation (CTI) Case Solution Other Similar Case Solutions like

Pfizer’s Centers for Therapeutic Innovation (CTI)

Share This